Search

everythinglearnresearchcommunity

for

Search:↓

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

LED light therapy is effective for skin and hair treatments but requires careful use to minimize risks.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Dental pulp stem cells are better for tissue repair, while fat tissue stem cells may be more suited for wound healing and hair growth.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

Inositol helped cure hair loss around rats' eyes and improved their growth.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Eclipta prostrata helps hair growth and maintains the growth phase by affecting certain growth factors.

A patient had painful swollen lymph nodes after a cosmetic skin and hair treatment, suggesting doctors should warn about this risk.

Phyllanthus urinaria extract may help treat hair loss by blocking a hair-related enzyme.

Syphilis can cause hair loss without other symptoms and should be considered when diagnosing unexplained hair loss.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Scalp-to-scalp skin grafts quickly heal and hide well under regrown hair, making them good for repairing large scalp defects.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Triamcinolone regrows hair better but relapses more than anthralin.

Common baldness can often be prevented and treated with available methods.

Most people using minoxidil for hair loss probably won't see significant improvement.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.